Disclosure statement
The authors report no conflict of interest.
Correction Statement
This article has been corrected with minor changes. These changes do not impact the academic content of the article.
Leukemia & Lymphoma
Volume 63, 2022 - Issue 14
Letters to the Editor
Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH)
Fernando Warleya Hospital Italiano de Buenos Aires, Buenos Aires, ArgentinaCorrespondence[email protected] [email protected]
https://orcid.org/0000-0002-2589-8190
https://orcid.org/0000-0002-2589-8190, , , , , , , , , & Ana Basquierag Hospital Privado Centro Medico de Cordoba, Cordoba, Argentinahttps://orcid.org/0000-0001-9892-5543
https://orcid.org/0000-0001-9892-5543 show all![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})